US4102671A
(en)
|
1975-07-29 |
1978-07-25 |
Shell Oil Company |
Control of weeds with N-substituted alanine compounds
|
GB1547758A
(en)
|
1975-07-29 |
1979-06-27 |
Shell Int Research |
Herbicidal composition
|
JPH01261381A
(ja)
|
1988-04-12 |
1989-10-18 |
Nippon Soda Co Ltd |
オキサ(チア)ジアゾール誘導体、その製造方法及び殺ダニ剤
|
DE3939346A1
(de)
|
1989-11-29 |
1991-06-06 |
Behringwerke Ag |
Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
FR2693461B1
(fr)
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
US5821225A
(en)
|
1992-07-14 |
1998-10-13 |
Syntex (U.S.A.) Inc. |
Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
|
US5977070A
(en)
|
1992-07-14 |
1999-11-02 |
Piazza; Christin Teresa |
Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
|
US5589452A
(en)
|
1992-07-14 |
1996-12-31 |
Syntex (U.S.A.) Inc. |
Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
|
GB9310635D0
(en)
|
1993-05-21 |
1993-07-07 |
Glaxo Group Ltd |
Chemical compounds
|
DE19517430A1
(de)
|
1995-05-12 |
1996-11-14 |
Boehringer Mannheim Gmbh |
Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode
|
IT1285405B1
(it)
|
1995-06-06 |
1998-06-03 |
Alza Corp |
Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.
|
UA51652C2
(uk)
|
1995-06-08 |
2002-12-16 |
Новартіс Аг |
Спосіб гідрування імінів
|
US5955574A
(en)
|
1995-07-13 |
1999-09-21 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. |
Analogs of parathyroid hormone
|
US5723577A
(en)
|
1995-07-13 |
1998-03-03 |
Biomeasure Inc. |
Analogs of parathyroid hormone
|
US7410948B2
(en)
|
1995-07-13 |
2008-08-12 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Analogs of parathyroid hormone
|
US6544949B1
(en)
|
1995-07-13 |
2003-04-08 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Analogs of parathyroid hormone
|
US5969095A
(en)
|
1995-07-13 |
1999-10-19 |
Biomeasure, Inc. |
Analogs of parathyroid hormone
|
DE19538687A1
(de)
|
1995-10-17 |
1997-04-24 |
Boehringer Mannheim Gmbh |
Stabile pharmazeutische Darreichungsformen enthaltend Parathormon
|
US5603694A
(en)
|
1995-10-17 |
1997-02-18 |
Brown; Joe E. |
Infusion coil apparatus and method for delivering fluid-based agents intravascularly
|
DE19539574A1
(de)
|
1995-10-25 |
1997-04-30 |
Boehringer Mannheim Gmbh |
Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
|
TWI240627B
(en)
|
1996-04-26 |
2005-10-01 |
Chugai Pharmaceutical Co Ltd |
Erythropoietin solution preparation
|
US6017924A
(en)
|
1996-06-27 |
2000-01-25 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
JP2000513362A
(ja)
|
1996-06-27 |
2000-10-10 |
リガンド・ファーマスーティカルス・インコーポレーテッド |
アンドロゲン受容体モジュレーター化合物及び方法
|
TW505654B
(en)
|
1996-07-30 |
2002-10-11 |
Hoffmann La Roche |
Synthesis of analogs of PTH and PTHrP
|
JP2002509431A
(ja)
|
1996-12-23 |
2002-03-26 |
イミュネックス・コーポレーション |
NF−κBのレセプター活性化因子−レセプターはTNFレセプタースーパーファミリーの一員である−
|
US6136784A
(en)
|
1997-01-08 |
2000-10-24 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
CZ298701B6
(cs)
|
1997-09-09 |
2007-12-27 |
F. Hoffman-La Roche Ag |
Lécivo pro hojení kostí a reparaci zlomenin
|
FR2770842B1
(fr)
|
1997-11-13 |
1999-12-17 |
Oreal |
Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
|
MY120063A
(en)
|
1997-12-09 |
2005-08-30 |
Lilly Co Eli |
Stabilized teriparatide solutions
|
US6770623B1
(en)
|
1997-12-09 |
2004-08-03 |
Eli Lilly And Company |
Stabilized teriparatide solutions
|
ATE302041T1
(de)
|
1997-12-11 |
2005-09-15 |
Alza Corp |
Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
|
DE69806963T2
(de)
|
1997-12-11 |
2002-11-21 |
Alza Corp., Mountain View |
Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
|
EP0922467A3
(en)
|
1997-12-12 |
2000-05-24 |
Takeda Chemical Industries, Ltd. |
Iontophoretic drug delivery
|
JP4154017B2
(ja)
|
1997-12-30 |
2008-09-24 |
久光製薬株式会社 |
イオントフォレーシス装置および薬物ユニット
|
US6091975A
(en)
|
1998-04-01 |
2000-07-18 |
Alza Corporation |
Minimally invasive detecting device
|
SE9801495D0
(sv)
|
1998-04-28 |
1998-04-28 |
Astra Ab |
Protein formulationa
|
US6316410B1
(en)
|
1999-09-22 |
2001-11-13 |
National Research Council Of Canada |
Parathyroid hormone analogues for the treatment of osteoporosis
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
AU1280701A
(en)
|
1999-11-17 |
2001-05-30 |
Novartis Ag |
Iontophoretic transdermal delivery of peptides
|
US6544553B1
(en)
|
1999-12-28 |
2003-04-08 |
Watson Pharmaceuticals, Inc. |
Dosage forms and methods for oral delivery of progesterone
|
IL150463A0
(en)
|
1999-12-30 |
2002-12-01 |
Signal Pharm Inc |
Compounds and methods for modulation of estrogen receptors
|
GB9930882D0
(en)
|
1999-12-30 |
2000-02-23 |
Nps Allelix Corp |
GLP-2 formulations
|
PL357163A1
(pl)
|
2000-01-28 |
2004-07-26 |
Endorecherche, Inc. |
Selektywne modulatory receptora estrogenu w kombinacji z estrogenami
|
US20010044431A1
(en)
|
2000-03-21 |
2001-11-22 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
US20050124537A1
(en)
|
2000-04-27 |
2005-06-09 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
AU8206401A
(en)
|
2000-08-03 |
2002-02-18 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
ATE309208T1
(de)
|
2000-08-23 |
2005-11-15 |
Akzo Nobel Nv |
10-aryl-11h-benzo(b)fluoren-derivate und analoga als östrogene mittel
|
EA014224B1
(ru)
|
2000-08-24 |
2010-10-29 |
Юниверсити Оф Теннесси Рисерч Фаундейшн |
Селективные модуляторы андрогенового рецептора и способы их применения
|
US7371721B2
(en)
|
2000-09-18 |
2008-05-13 |
Sanos Bioscience A/S |
Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
|
US7186683B2
(en)
|
2000-09-18 |
2007-03-06 |
Sanos Bioscience A/S |
Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
|
JP4659336B2
(ja)
|
2000-10-26 |
2011-03-30 |
アルザ・コーポレーシヨン |
被覆された微細突出物を有する経皮的薬剤配達装置
|
BR0209046A
(pt)
|
2001-04-20 |
2004-11-09 |
Alza Corp |
Disposição de microprojeção que possui um agente benéfico contendo revestimento
|
MXPA04000134A
(es)
|
2001-06-26 |
2005-06-06 |
Abgenix Inc |
Anticuerpos para ligandos de osteoprotegerina.
|
JP2003107278A
(ja)
|
2001-09-28 |
2003-04-09 |
Nippon Sheet Glass Co Ltd |
光モジュール及び光モジュールの作製方法
|
WO2003011824A1
(en)
|
2001-07-31 |
2003-02-13 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
EP1418900A4
(en)
|
2001-08-13 |
2006-01-25 |
Merck & Co Inc |
SELECTIVE ESTROGEN RECEPTOR MODULATORS
|
US6881203B2
(en)
|
2001-09-05 |
2005-04-19 |
3M Innovative Properties Company |
Microneedle arrays and methods of manufacturing the same
|
US8853266B2
(en)
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
HUP0402605A2
(hu)
|
2001-12-20 |
2005-06-28 |
Alza Corporation |
Eszköz mikroszkopikus bemetszések ejtésére állat bőrszövetén
|
WO2003063859A1
(en)
|
2002-01-14 |
2003-08-07 |
Nordic Bioscience A/S |
Suppression of cartilage degradation via the estrogen receptor
|
CA2472956A1
(en)
|
2002-02-14 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Formulation strategies in stabilizing peptides in organic solvents and in dried states
|
CA2474171A1
(en)
|
2002-02-15 |
2003-08-21 |
Endorecherche, Inc. |
Biphenil derivatives and their use as antiandrogenic agents
|
AU2003237084C1
(en)
|
2002-04-24 |
2009-03-26 |
Merck Sharp & Dohme Corp. |
Estrogen receptor modulators
|
US7405234B2
(en)
|
2002-05-17 |
2008-07-29 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
TW200407324A
(en)
|
2002-05-17 |
2004-05-16 |
Bristol Myers Squibb Co |
Bicyclic modulators of androgen receptor function
|
WO2003099849A2
(en)
|
2002-05-23 |
2003-12-04 |
Michael Holick |
Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
|
TW200307553A
(en)
|
2002-05-24 |
2003-12-16 |
Akzo Nobel Nv |
Treatment of post-menopausal complaints in breast cancer patients
|
AU2003251527A1
(en)
|
2002-06-13 |
2003-12-31 |
Beth Israel Deaconess Medical Center, Inc. |
Analogs of parathyroid hormone and pth-related protein as bone anabolic agents
|
WO2004007520A2
(en)
|
2002-07-12 |
2004-01-22 |
Medarex, Inc. |
Methods and compositions for preventing oxidative degradation of proteins
|
EP1523367A1
(en)
|
2002-07-19 |
2005-04-20 |
3M Innovative Properties Company |
Microneedle devices and microneedle delivery apparatus
|
US7411039B2
(en)
|
2002-10-14 |
2008-08-12 |
Novo Nordisk A/S |
GLP-2 compounds, formulations, and uses thereof
|
BR0314920A
(pt)
|
2002-10-14 |
2005-08-02 |
Novo Nordisk As |
Peptìdeo glp-2, construto de polinucleotìdeo, célula hospedeira, derivado de glp-2 compreendendo um peptìdeo glp-2, composição farmacêutica, uso de um derivado de glp-2, método para o tratamento de uma insuficiência intestinal ou outra condição acarretando a má absorção de nutrientes no intestino, método para o tratamento de doenças, e, método para produzir o peptìdeo glp-2
|
US8133505B2
(en)
|
2002-10-31 |
2012-03-13 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized medications
|
IL152574A
(en)
|
2002-10-31 |
2009-09-22 |
Transpharma Medical Ltd |
A system for passing through the skin of dry items or dried medicines
|
US7662404B2
(en)
|
2002-10-31 |
2010-02-16 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
|
US7383084B2
(en)
|
2002-10-31 |
2008-06-03 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized medications
|
EP1567178A4
(en)
|
2002-11-01 |
2009-07-15 |
Amgen Inc |
MODULATORS OF RECEPTORS FOR NEUTRAL THERAPY HORMONE AND SIDE-HORSE HORMONE-RELATED PROTEINS
|
CA2504044A1
(en)
|
2002-11-01 |
2004-05-21 |
Merck & Co., Inc. |
Carbonylamino-benzimidazole derivatives as androgen receptor modulators
|
DE60332769D1
(de)
|
2002-11-07 |
2010-07-08 |
Organon Nv |
Indole, die sich zur behandlung von mit dem androgenrezeptor in zusammenhang stehenden krankheiten eignen
|
UA79504C2
(en)
|
2002-11-07 |
2007-06-25 |
Organon Nv |
Indols for treating diseases associated with androgen receptors
|
US7632858B2
(en)
|
2002-11-15 |
2009-12-15 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
CA2512000C
(en)
|
2002-12-26 |
2011-08-09 |
Eisai Co., Ltd. |
Selective estrogen receptor modulator
|
JP2006523196A
(ja)
|
2003-03-11 |
2006-10-12 |
ニューロサーチ、アクティーゼルスカブ |
新規kcnqチャネルを調節する化合物及びその医薬用途
|
EP1471286A1
(en)
|
2003-04-24 |
2004-10-27 |
Umbra Cuscinetti S.p.A. |
Ball screw
|
WO2005000795A2
(en)
|
2003-06-10 |
2005-01-06 |
Smithkline Beecham Corporation |
Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
|
US20060142387A1
(en)
|
2003-06-10 |
2006-06-29 |
Rodolfo Cadilla |
Chemical compounds
|
FI20030958A0
(fi)
|
2003-06-27 |
2003-06-27 |
Orion Corp |
Uusia yhdisteitä
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
EP1638468B1
(en)
|
2003-06-30 |
2007-08-15 |
Alza Corporation |
Method for coating skin piercing microprojections
|
CA2530531A1
(en)
|
2003-06-30 |
2005-01-20 |
Alza Corporation |
Formulations for coated microprojections containing non-volatile counterions
|
EP1643978A1
(en)
|
2003-07-04 |
2006-04-12 |
Nycomed Danmark A/S |
Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
|
WO2005014034A1
(en)
|
2003-07-14 |
2005-02-17 |
Nps Allelix Corp. |
Stabilized formulation of parathyroid hormone
|
US7141544B2
(en)
|
2003-10-10 |
2006-11-28 |
Baxter International, Inc. |
Stabilization of pharmaceutical protein formulations with small peptides
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
GB0324551D0
(en)
|
2003-10-21 |
2003-11-26 |
Karobio Ab |
Novel compounds
|
CA2543280A1
(en)
|
2003-10-28 |
2005-05-19 |
Alza Corporation |
Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections
|
EP1680154B1
(en)
|
2003-10-31 |
2012-01-04 |
ALZA Corporation |
Self-actuating applicator for microprojection array
|
US7256208B2
(en)
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
AU2004292954A1
(en)
|
2003-11-13 |
2005-06-09 |
Alza Corporation |
Composition and apparatus for transdermal delivery
|
US20070129409A1
(en)
|
2003-11-20 |
2007-06-07 |
Lain-Yen Hu |
Androgen receptor modulators
|
BRPI0416822A
(pt)
|
2003-11-21 |
2007-03-06 |
Alza Corp |
método e sistema de liberação de vacina transdérmica com ultra-som
|
IL159273A0
(en)
|
2003-12-09 |
2004-06-01 |
Transpharma Medical Ltd |
Transdermal delivery system for sustained release of polypeptides
|
AU2003297904A1
(en)
|
2003-12-12 |
2005-07-14 |
University Of Maryland, Baltimore |
Immunomodulatory compounds that target and inhibit the py+3 binding site of tyrosene kinase p56 lck sh2 domain
|
CA2551737C
(en)
|
2004-01-07 |
2009-11-10 |
Endorecherche, Inc. |
Helix 12 directed steroidal pharmaceutical products
|
JP4909086B2
(ja)
|
2004-01-22 |
2012-04-04 |
イーライ リリー アンド カンパニー |
血管運動性症候の治療のための選択的エストロゲン受容体モジュレーター
|
IL160033A0
(en)
|
2004-01-25 |
2004-06-20 |
Transpharma Medical Ltd |
Transdermal delivery system for polynucleotides
|
US7820702B2
(en)
|
2004-02-04 |
2010-10-26 |
Bristol-Myers Squibb Company |
Sulfonylpyrrolidine modulators of androgen receptor function and method
|
TWI359026B
(en)
|
2004-02-12 |
2012-03-01 |
Sankyo Co |
Pharmaceutical composition for the osteoclast rela
|
WO2005085185A1
(en)
|
2004-03-03 |
2005-09-15 |
Smithkline Beecham Corporation |
Aniline derivatives as selective androgen receptor modulators
|
US7696241B2
(en)
|
2004-03-04 |
2010-04-13 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
US7388027B2
(en)
|
2004-03-04 |
2008-06-17 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
US7625923B2
(en)
|
2004-03-04 |
2009-12-01 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
GB0405033D0
(en)
|
2004-03-05 |
2004-04-07 |
Karobio Ab |
Novel pharmaceutical compositions
|
WO2005090282A1
(en)
|
2004-03-12 |
2005-09-29 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
JP4402992B2
(ja)
|
2004-03-18 |
2010-01-20 |
株式会社日立製作所 |
バックアップシステム及び方法並びにプログラム
|
WO2005099707A1
(en)
|
2004-04-08 |
2005-10-27 |
Merck & Co., Inc. |
17 beta-acetamide-4-azasteroids as androgen receptor modulators
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
AU2005243240B2
(en)
|
2004-05-03 |
2012-03-15 |
Janssen Pharmaceutica N.V. |
Novel indole derivatives as selective androgen receptor modulators (SARMS)
|
CN101151048A
(zh)
|
2004-05-10 |
2008-03-26 |
纳斯泰克制药公司 |
增强甲状旁腺激素粘膜递送的组合物和方法
|
WO2005108351A1
(en)
|
2004-05-11 |
2005-11-17 |
Pfizer Products Inc. |
Benzonitrile derivatives to treat musculoskeletal frailty
|
AU2005244734A1
(en)
|
2004-05-13 |
2005-12-01 |
Alza Corporation |
Apparatus and method for transdermal delivery of parathyroid hormone agents
|
EP1765406A4
(en)
|
2004-05-21 |
2012-11-28 |
Mediplex Corp |
ADDITIVES FOR IMPROVED MUCOSAL ABSORPTION OF THERAPEUTIC AGENTS
|
US7906137B2
(en)
|
2004-05-21 |
2011-03-15 |
Mediplex Corporation, Korea |
Delivery agents for enhancing mucosal absorption of therapeutic agents
|
US20090069226A1
(en)
|
2004-05-28 |
2009-03-12 |
Amylin Pharmaceuticals, Inc. |
Transmucosal delivery of peptides and proteins
|
TW200621282A
(en)
|
2004-08-13 |
2006-07-01 |
Wyeth Corp |
Stabilizing formulations
|
CN101072780B
(zh)
|
2004-09-20 |
2010-06-23 |
詹森药业有限公司 |
用作类固醇性激素受体调节剂的新的含杂原子的四环衍生物
|
AU2005292345B9
(en)
|
2004-09-30 |
2011-12-15 |
Janssen Pharmaceutica N.V. |
Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
|
US8143425B2
(en)
|
2004-10-12 |
2012-03-27 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
EP1809275A1
(en)
|
2004-10-13 |
2007-07-25 |
Smithkline Beecham Corporation |
Chemical compounds
|
EP1807076A4
(en)
|
2004-10-29 |
2010-06-02 |
Merck Sharp & Dohme |
N- (PYRIDIN-3-YL) -2-PHENYLBUTANAMIDES AS ANDROGEN RECEPTOR MODULATORS
|
AU2005307003B2
(en)
|
2004-11-16 |
2011-10-13 |
Janssen Pharmaceutica N.V. |
Novel heterocycle derivatives useful as selective androgen receptor modulators (SARMs)
|
EP1848498A4
(en)
|
2004-11-18 |
2009-12-16 |
Transpharma Medical Ltd |
ASSOCIATED MICRO-CHANNEL PRODUCTION AND IONTOPHORESIS FOR TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS
|
JP4927751B2
(ja)
|
2004-11-18 |
2012-05-09 |
スリーエム イノベイティブ プロパティズ カンパニー |
マイクロニードルアレイのコーティング方法
|
US8057842B2
(en)
|
2004-11-18 |
2011-11-15 |
3M Innovative Properties Company |
Method of contact coating a microneedle array
|
CN101119993B
(zh)
|
2005-01-10 |
2015-03-04 |
阿卡蒂亚药品公司 |
作为选择性雄激素受体调节剂的氨基苯基衍生物
|
WO2006079019A2
(en)
|
2005-01-21 |
2006-07-27 |
Alza Corporation |
Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion
|
EP1871379A4
(en)
|
2005-04-15 |
2010-06-02 |
Glaxosmithkline Llc |
CYANOARYLAMINE
|
MX2007014053A
(es)
|
2005-05-13 |
2008-02-05 |
Lilly Co Eli |
N-arilpirrolidinas substituidas como moduladores selectivos de receptor de androgeno.
|
KR100700869B1
(ko)
|
2005-06-03 |
2007-03-29 |
재단법인 목암생명공학연구소 |
Pth, 완충제 및 안정제를 포함하는 안정한 pth조성물
|
US20090170907A1
(en)
|
2005-06-06 |
2009-07-02 |
Smithkline Beecham Corporation |
Chemical Compounds
|
US7829589B2
(en)
|
2005-06-10 |
2010-11-09 |
Elixir Pharmaceuticals, Inc. |
Sulfonamide compounds and uses thereof
|
DE602006012322D1
(de)
|
2005-06-24 |
2010-04-01 |
Lilly Co Eli |
Als androgen-rezeptor-modulatoren verwendbare tetrahydrocarbazol-derivate
|
WO2007005887A2
(en)
|
2005-07-01 |
2007-01-11 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds, compositions and uses thereof
|
US20070021216A1
(en)
|
2005-07-19 |
2007-01-25 |
Sony Ericsson Mobile Communications Ab |
Seamless gaming method and apparatus
|
EP1911743B8
(en)
|
2005-08-01 |
2013-01-16 |
Takeda Pharmaceutical Company Limited |
Cyclic amine compound
|
US20070034846A1
(en)
|
2005-08-09 |
2007-02-15 |
Suchin Ratanasiriwilai |
Fastening clip for attaching rails and posts in fence structure and attachment method of the same
|
JP2008303145A
(ja)
|
2005-09-22 |
2008-12-18 |
Takeda Chem Ind Ltd |
Grk阻害剤からなる強心薬
|
CA2629193C
(en)
|
2005-11-18 |
2016-03-29 |
3M Innovative Properties Company |
Coatable compositions, coatings derived therefrom and microarrays having such coatings
|
TW200730505A
(en)
|
2005-12-07 |
2007-08-16 |
Merck & Co Inc |
Polymorphs of an androgen receptor modulator
|
KR100645734B1
(ko)
|
2005-12-14 |
2006-11-15 |
주식회사 경동나비엔 |
난방/온수 겸용 콘덴싱 보일러의 열교환기
|
US8632801B2
(en)
|
2005-12-28 |
2014-01-21 |
Alza Corporation |
Stable therapeutic formulations
|
AU2007208139B2
(en)
|
2006-01-24 |
2012-09-27 |
Janssen Pharmaceutica N.V. |
2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
|
EP1991523B1
(en)
|
2006-03-03 |
2012-08-15 |
Orion Corporation |
Selective androgen receptor modulators
|
WO2007106597A2
(en)
|
2006-03-15 |
2007-09-20 |
Alza Corporation |
Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia
|
JP4144630B2
(ja)
|
2006-04-14 |
2008-09-03 |
ソニー株式会社 |
撮像装置
|
US9119945B2
(en)
|
2006-04-20 |
2015-09-01 |
3M Innovative Properties Company |
Device for applying a microneedle array
|
JP5362552B2
(ja)
|
2006-04-20 |
2013-12-11 |
ヴェロシス,インク. |
マイクロチャネルプロセス技術を用いて非ニュートン流体を処理し、および/または形成させるためのプロセス
|
CN101437490A
(zh)
|
2006-04-20 |
2009-05-20 |
安美基公司 |
稳定乳液配方
|
CA2656067C
(en)
|
2006-06-23 |
2014-08-12 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
EP1876313A2
(en)
|
2006-07-05 |
2008-01-09 |
Andrell Investments Pty Ltd. |
An extrusion for fixing cladding boards to a support structure
|
PL2038252T3
(pl)
|
2006-07-12 |
2017-03-31 |
University Of Tennessee Research Foundation |
Podstawione acyloanilidy i sposoby ich zastosowania
|
BRPI0713200A2
(pt)
|
2006-07-19 |
2012-04-10 |
Osurf Ohio State University Res Foundation |
moduladores seletivos de receptores de androgênio, seus análogos e derivados, e seus usos
|
US8599144B2
(en)
|
2006-07-31 |
2013-12-03 |
Cypress Semiconductor Corporation |
Grounded button for capacitive sensor
|
JP4345784B2
(ja)
|
2006-08-21 |
2009-10-14 |
ソニー株式会社 |
音響収音装置及び音響収音方法
|
EA016853B1
(ru)
|
2006-08-24 |
2012-08-30 |
Юниверсити Оф Теннесси Рисерч Фаундейшн |
Замещенные ациланилиды и их применение
|
AU2007287510B2
(en)
|
2006-08-25 |
2012-08-30 |
Ares Trading S.A. |
Treatment of cartilage disorders with FGF-18
|
JP5275236B2
(ja)
|
2006-09-29 |
2013-08-28 |
スミスクライン ビーチャム コーポレーション |
置換されたインドール化合物
|
DK2957278T3
(en)
|
2006-10-03 |
2017-07-31 |
Radius Health Inc |
STABLE COMPOSITION COMPREHENSIVE PTHRP AND APPLICATIONS THEREOF
|
US7803770B2
(en)
|
2006-10-03 |
2010-09-28 |
Radius Health, Inc. |
Method of treating osteoporosis comprising administration of PTHrP analog
|
WO2008044033A1
(en)
|
2006-10-11 |
2008-04-17 |
Astrazeneca Ab |
Amide derivatives
|
UA98777C2
(en)
|
2006-11-20 |
2012-06-25 |
Эли Лилли Энд Компани |
Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
|
US7500575B2
(en)
|
2006-11-28 |
2009-03-10 |
Caper, Phillips & Associates |
Crane trim, list, skew and snag protection system
|
US20080127717A1
(en)
|
2006-11-30 |
2008-06-05 |
Chevron Oronite S.A. |
Alternative pressure viscometer device
|
US20100030100A1
(en)
|
2007-02-06 |
2010-02-04 |
Hisamitsu Pharmaceutical Co., Inc. |
Microneedle Device For Diagnosis Of Allergy
|
WO2008121602A1
(en)
|
2007-03-29 |
2008-10-09 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2008124000A2
(en)
|
2007-04-02 |
2008-10-16 |
Ligand Pharmaceuticals Incorporated |
Thiazole derivatives as androgen receptor modulator compounds
|
US9284345B2
(en)
|
2007-04-12 |
2016-03-15 |
Endorecherche, Inc. |
17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
|
CN102446669B
(zh)
|
2007-04-12 |
2015-06-24 |
株式会社尼康 |
放电灯、连接用线缆、光源装置及曝光装置
|
WO2008128100A1
(en)
|
2007-04-13 |
2008-10-23 |
The Regents Of The University Of California |
Small-molecule inhibitors of the androgen receptor
|
AU2008241470B2
(en)
|
2007-04-16 |
2013-11-07 |
Corium Pharma Solutions, Inc. |
Solvent-cast microneedle arrays containing active
|
GB0707938D0
(en)
|
2007-04-25 |
2007-05-30 |
Univ Strathclyde |
Precipitation stabilising compositions
|
MX2009013575A
(es)
|
2007-06-12 |
2010-07-02 |
Schering Corp |
Biomarcador de histona h2ax (hh2ax) para sensibilidad de inhibidores de farnesil proteina transferasa.
|
EP2155226A4
(en)
|
2007-06-14 |
2010-07-28 |
Univ California |
COMPOUNDS FOR INHIBITING AGGREGATION OF PROTEINS AND METHODS OF MAKING AND USING SAME
|
US20120150023A1
(en)
|
2007-08-06 |
2012-06-14 |
Kaspar Roger L |
Microneedle arrays for active agent delivery
|
KR20100049644A
(ko)
|
2007-08-07 |
2010-05-12 |
다케다 야쿠힌 고교 가부시키가이샤 |
안드로겐 수용체 조절제로서의 피롤리딘-2-온 유도체
|
WO2009040548A1
(en)
|
2007-09-28 |
2009-04-02 |
The Queen's University Of Belfast |
Delivery device and method
|
WO2009054988A1
(en)
|
2007-10-23 |
2009-04-30 |
Alza Corporation |
Transdermal sustained release drug delivery
|
EP2052736A1
(en)
|
2007-10-26 |
2009-04-29 |
Nycomed Danmark ApS |
Parathyroid hormone formulations und uses thereof
|
WO2009065126A2
(en)
|
2007-11-16 |
2009-05-22 |
Boston Protein Solutions |
Excipients for protein stabilization
|
WO2009082437A2
(en)
|
2007-12-21 |
2009-07-02 |
Ligand Pharmaceuticals Incorporated |
Selective androgen receptor modulators (sarms) and uses thereof
|
US8067448B2
(en)
|
2008-02-22 |
2011-11-29 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
WO2009133861A1
(ja)
|
2008-04-28 |
2009-11-05 |
武田薬品工業株式会社 |
環状アミン化合物
|
WO2009137104A1
(en)
|
2008-05-09 |
2009-11-12 |
Radius Health, Inc. |
Combination therapy for breastcancer comprising an antiestrogenic agent
|
US8486943B2
(en)
|
2008-05-16 |
2013-07-16 |
Eli Lilly And Company |
Tetrahydrocyclopenta[b]indole androgen receptor modulators
|
WO2010022176A1
(en)
|
2008-08-19 |
2010-02-25 |
Ferring International Center S.A. |
Methods of treatment for skeletal conditons
|
CN106539756A
(zh)
|
2008-10-15 |
2017-03-29 |
精达制药公司 |
高浓缩药物颗粒、制剂、混悬剂及其应用
|
ES2548378T3
(es)
|
2008-11-04 |
2015-10-16 |
Aska Pharmaceutical Co., Ltd. |
Composición acuosa que contiene hormona foliculoestimulante
|
JP2012509106A
(ja)
|
2008-11-18 |
2012-04-19 |
スリーエム イノベイティブ プロパティズ カンパニー |
中空のマイクロニードルアレイ及び方法
|
WO2010074239A1
(ja)
|
2008-12-26 |
2010-07-01 |
久光製薬株式会社 |
マイクロニードルデバイス
|
US20100203014A1
(en)
|
2009-02-04 |
2010-08-12 |
Aegis Therapeutics Llc |
Zwitterionic buffered acidic peptide and protein formulations
|
US20100226966A1
(en)
|
2009-03-03 |
2010-09-09 |
Daddona Peter E |
Method for transdermal controlled release drug delivery
|
WO2010118287A1
(en)
|
2009-04-10 |
2010-10-14 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
JP5820805B2
(ja)
|
2009-04-24 |
2015-11-24 |
コリウム インターナショナル, インコーポレイテッド |
マイクロプロジェクションのアレイの製造のためのプロセス
|
CA2769102C
(en)
|
2009-07-31 |
2017-09-19 |
3M Innovative Properties Company |
Hollow microneedle arrays
|
KR101844080B1
(ko)
|
2009-10-16 |
2018-03-30 |
가부시키가이샤 한도오따이 에네루기 켄큐쇼 |
액정 표시 장치 및 이를 구비한 전자 장치
|
WO2011051916A2
(en)
|
2009-11-02 |
2011-05-05 |
Universite De Geneve |
Stabilized protein formulations and use thereof
|
EP2504391B1
(en)
*
|
2009-11-25 |
2018-07-25 |
Dow Global Technologies LLC |
Molded polymeric article with low haze and high clarity
|
US20110172609A1
(en)
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
CN101912600B
(zh)
|
2010-01-11 |
2014-01-29 |
杨国汉 |
改善胰岛素在溶液中稳定性的方法
|
CA2788907A1
(en)
|
2010-02-04 |
2011-08-11 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
IE20100174A1
(en)
|
2010-03-25 |
2012-02-29 |
Trinity College Dublin |
Transdermal administration of peptides
|
AU2011248108B2
(en)
|
2010-05-04 |
2016-05-26 |
Corium Pharma Solutions, Inc. |
Method and device for transdermal delivery of parathyroid hormone using a microprojection array
|
CA2799183A1
(en)
|
2010-05-12 |
2011-11-17 |
Radius Health, Inc. |
Therapeutic regimens
|
CA2800253C
(en)
|
2010-05-28 |
2022-07-12 |
3M Innovative Properties Company |
Aqueous formulations for coating microneedle arrays
|
RS56042B1
(sr)
*
|
2010-06-10 |
2017-09-29 |
Seragon Pharmaceuticals Inc |
Modulatori estrogenih receptora i njihove upotrebe
|
AU2011312490B2
(en)
|
2010-09-28 |
2015-06-25 |
Radius Pharmaceuticals, Inc. |
Selective androgen receptor modulators
|
WO2012075375A1
(en)
|
2010-12-02 |
2012-06-07 |
Lanco Biosciences, Inc. |
Delivery of parathyroid hormones by microinjection systems
|
EP2680871A4
(en)
|
2011-03-01 |
2015-04-22 |
Sloan Kettering Inst Cancer |
SYMBOLS HORMONE ANALOGUE, COMPOSITIONS THEREOF AND USES THEREOF
|
AU2012245301B2
(en)
|
2011-04-22 |
2016-05-19 |
3M Innovative Properties Company, A Wholly Owned Subsidiary Of 3M Company |
Method of drug delivery for PTH, PTHrP and related peptides
|
CN104080441B
(zh)
|
2011-11-30 |
2020-02-28 |
3M创新有限公司 |
包括肽治疗剂和氨基酸的微针装置、制备和使用其的方法
|
GB201217439D0
(en)
|
2012-09-28 |
2012-11-14 |
Topotarget As |
Combination therapy
|
WO2014203129A1
(en)
*
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Combinations of benzopyran compounds, compositions and uses thereof
|
US9421264B2
(en)
|
2014-03-28 |
2016-08-23 |
Duke University |
Method of treating cancer using selective estrogen receptor modulators
|
IL255148B2
(en)
|
2015-04-29 |
2023-04-01 |
Radius Pharmaceuticals Inc |
1901 rad for use in a method to inhibit a cancerous growth or induce tumor regression in a patient who is resistant to the drug and/or has cancer positive for an estrogen receptor alpha mutation
|
KR102322802B1
(ko)
*
|
2017-01-05 |
2021-11-04 |
래디어스 파마슈티컬스, 인코포레이티드 |
Rad1901-2hcl의 다형 형태
|